Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Biosimilars Growth At Biogen Still Pending As Unfavorable Market Takes Its Toll
Company Expects Significant Contributions From Byooviz From Next Year
01 Nov 2022
•
By
Chloe Kent
Biogen expects a return to form by 2025 • Source: Shutterstock
More from Earnings
More from Business